Accelerating accessible
early cancer detection
Powered by OncoSeek®
Advancing multi-cancer detection
Worldwide, 19.3 million people are diagnosed with cancer each year, and the numbers are growing. Nearly one in six deaths is caused by cancer. Detecting cancer earlier increases chances of survival and reduces the negative impact on quality of life. OncoInv supports the implementation of structured multi-cancer detection programs using the OncoSeek® blood test.
OncoSeek® is a clinically validated and scalable blood test for cancer detection
OncoSeek® is a software-based blood test that analyses protein tumor marker concentrations using a machine learning algorithm. The test detects nine high-mortality cancer types and provides both a Probability of Cancer score and a predicted Tissue of Origin. OncoSeek® is scientifically validated, CE-marked, and designed to integrate into existing healthcare settings.
Learn more about OncoSeek®About Oncolnv
OncoInv is an initiative of Inspire2Live. Our mission is to improve access to cancer treatment worldwide through earlier cancer detection. OncoInv collaborates with SeekIn, the developer of OncoSeek®, to support that mission.
Learn more about OncoInv
News & Updates
Multi-cancer detection beyond the test: reflections from Barcelona
April 16th, 2026
What does it take to move a promising technology from research into responsible clinical practice? That was a central question at OncoInv's expert meeting at Barcelona Health Hub..
Read more
OncoInv convenes second expert meeting on multi-cancer detection in Barcelona
March 26th, 2026
Following the expert meeting in Madrid in February, OncoInv continues the conversation on multi-cancer detection (MCD) with a second session at Barcelona Health Hub.
Read more
Expert roundtable in Madrid discusses integration of multi-cancer detection into clinical practice
February 12th, 2026
OncoInv recently hosted an expert roundtable at Madrid Health Hub, bringing together clinicians, laboratory leaders and researchers to discuss the evolving role of multi-cancer detection (MCD) tests in oncology care...
Read more